Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Magnetic Resonance in Medicine|May 1, 1988
Renal imaging studies at 1.5 and 9.4 T: effects of diureticsS K Sarkar, G A Holland, R E Lenkinski, et al.
Magnetic Resonance in Medicine|February 1, 1991
Yb-DTPA, a novel contrast agent in magnetic resonance imaging: application to rat kidneyS K Sarkar, R E Rycyna, R E Lenkinski, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1986
Essential hereditary hypertension in dogs: a new animal modelK C Bovée, M P Littman, F Saleh, et al.
British Journal of Pharmacology|April 1, 1990
Effect of cyclo-oxygenase blockade on the renal actions of vasopressin and SK&F 105494 in the rhesus monkeyD P Brooks, N C Caldwell, P F Koster, et al.
Toxicologic Pathology|March 1, 1994
The application of toxicokinetic data to dosage selection in toxicology studiesD G Morgan, A S Kelvin, L B Kinter, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogsC R Albrightson-Winslow, N Caldwell, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta)D P Brooks, P F Koster, C R Albrightson-Winslow, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogsN Caldwell, B Brickson, L B Kinter, et al.
Clinical Science (London, England : 1979)|December 1, 1989
Production of methylguanidine in dogs with acute and chronic renal failureD P Brooks, G R Rhodes, P Woodward, et al.
Pageof 6